Curcumin Protects Neonatal Rat Cardiomyocytes against High Glucose-Induced Apoptosis via PI3K/Akt Signalling Pathway

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Yu, Wei ^a   Zha, Wenliang ^a   Ke, Zhiqiang ^a   Min, Qing ^a   Li, Cairong ^a   Sun, Huirong ^b   Liu, Chao ^a  

^a HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CURCUMIN; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P47; PROTEIN P47 PHOX; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIOXIDANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CARDIAC MUSCLE CELL; CARDIOTOXICITY; CELL CULTURE; CELL PROTECTION; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NEWBORN; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; APOPTOSIS; CARDIOTOXICITY; CELLS, CULTURED; CURCUMIN; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; LIPID PEROXIDATION; MYOCYTES, CARDIAC; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 84959562114     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/4158591     Document Type: Article

References (34)

1. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, "Global estimates of diabetes prevalence for 2013 and projections for 2035," Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137-149, 2014.
2. W. B. Kannel and D. L. McGee, "Diabetes and cardiovascular disease. The Framingham study," The Journal of the American Medical Association, vol. 241, no. 19, pp. 2035-2038, 1979.
3. Z. V. Wang and J. A. Hill, "Diabetic cardiomyopathy: catabolism driving metabolism," Circulation, vol. 131, no. 9, pp. 771-773, 2015.
4. S. Rubler, J. Dlugash, Y. Z. Yuceoglu, T. Kumral, A. W. Branwood, and A. Grishman, "New type of cardiomyopathy associated with diabetic glomerulosclerosis," The American Journal of Cardiology, vol. 30, no. 6, pp. 595-602, 1972.
5. I. G. Poornima, P. Parikh, and R. P. Shannon, "Diabetic cardiomyopathy: the search for a unifying hypothesis," Circulation Research, vol. 98, no. 5, pp. 596-605, 2006.
6. A. Frustaci, J. Kajstura, C. Chimenti et al., "Myocardial cell death in human diabetes," Circulation Research, vol. 87, no. 12, pp. 1123-1132, 2000.
7. C. He, H. Zhu, H. Li, M.-H. Zou, and Z. Xie, "Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes," Diabetes, vol. 62, no. 4, pp. 1270-1281, 2013.
8. R. Tarquini, C. Lazzeri, L. Pala, C. M. Rotella, and G. F. Gensini, "The diabetic cardiomyopathy," Acta Diabetologica, vol. 48, no. 3, pp. 173-181, 2011.
9. J. Kajstura, F. Fiordaliso, A. M. Andreoli et al., "IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress," Diabetes, vol. 50, no. 6, pp. 1414-1424, 2001.
10. A. Modesti, I. Bertolozzi, T. Gamberi et al., "Hyperglycemia activates JAK2 signaling pathway in human failing myocytes via angiotensin II-mediated oxidative stress," Diabetes, vol. 54, no. 2, pp. 394-401, 2005.
11. F. Fiordaliso, R. Bianchi, L. Staszewsky et al., "Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats," Journal of Molecular and Cellular Cardiology, vol. 37, no. 5, pp. 959-968, 2004.
12. J.-M. Zingg, S. T. Hasan, and M. Meydani, "Molecular mechanisms of hypolipidemic effects of curcumin," BioFactors,vol.39, no. 1, pp. 101-121, 2013.
13. M. Izem-Meziane, B. Djerdjouri, S. Rimbaud et al., "Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: protective effect of curcumin," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 302, no. 23, pp. 665-674, 2012.
14. Y. Pan, Y. Wang, Y. Zhao et al., "Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy," Diabetes,vol.63,no. 10, pp. 3497-3511, 2014.
15. W. Yu, J. Wu, F. Cai et al., "Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats," PLoS ONE,vol. 7, no. 12, Article ID e52013, 2012.
16. C. W. Younce, M. A. Burmeister, and J. E. Ayala, "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a," American Journal of Physiology - Cell Physiology, vol. 304, no. 6, pp. C508-C518, 2013.
17. J. Zielonka, M. Hardy, and B. Kalyanaraman, "HPLC study of oxidation products of hydroethidine in chemical and biological systems: ramifications in superoxide measurements," Free Radical Biology and Medicine, vol. 46, no. 3, pp. 329-338, 2009.
18. J. Li, H. Zhu, E. Shen, L. Wan, J. M. O. Arnold, and T. Peng, "Deficiency of Rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes," Diabetes, vol. 59, no. 8, pp. 2033-2042, 2010.
19. Y. Zhang, S. A. Babcock, N. Hu, J. R. Maris, H. Wang, and J. Ren, "Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function," BMC Medicine, vol. 10, article 40, 2012.
20. B. DeBosch, I. Treskov, T. S. Lupu et al., "Akt1 is required for physiological cardiac growth," Circulation, vol. 113, no. 17, pp. 2097-2104, 2006.
21. Y. Liu, Z. Huang, L. Wang et al., "Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats," Journal of Pharmacological Sciences, vol. 127, no. 3, pp. 260-274, 2015.
22. F. Giacco and M. Brownlee, "Oxidative stress and diabetic complications," Circulation Research, vol. 107, no. 9, pp. 1058- 1070, 2010.
23. W.-W. Kuo, W.-J. Wang, C.-Y. Tsai, C.-L. Way, H.-H. Hsu, and L.-M. Chen, "Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation," International Journal of Cardiology, vol. 168, no. 1, pp. 270-280, 2013.
24. K.-H. Tsai, W.-J. Wang, C.-W. Lin et al., "NADPH oxidase-derived superoxide anion-induced apoptosis is mediated via the JNK-dependent activation of NF-κB in cardiomyocytes exposed to high glucose," Journal of Cellular Physiology, vol. 227, no. 4, pp. 1347-1357, 2012.
25. P. L. Hordijk, "Regulation of NADPH oxidases: the role of Rac proteins," Circulation Research, vol. 98, no. 4, pp. 453-462, 2006.
26. E. Shen, Y. Li, Y. Li et al., "Rac1 is required for cardiomyocyte apoptosis during hyperglycemia," Diabetes, vol. 58, no. 10, pp. 2386-2395, 2009.
27. X. Sun, R.-C. Chen, Z.-H. Yang et al., "Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis," Food and Chemical Toxicology, vol. 63, pp. 221-232, 2014.
28. R. G. Katare, A. Caporali, A. Oikawa, M. Meloni, C. Emanuel, and P. Madeddu, "Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway," Circulation: Heart Failure, vol. 3, no. 2, pp. 294-305, 2010.
29. Z.-Z. Yang, O. Tschopp, N. Di-Poï et al., "Dosage-dependent effects of Akt1/protein kinase Bα (PKBα) and Akt3/PKBγ on thymus, skin, and cardiovascular and nervous system development in mice," Molecular and Cellular Biology, vol. 25, no. 23, pp. 10407-10418, 2005.
30. H. Cho, J. Mu, J. K. Kim et al., "Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)," Science, vol. 292, no. 5522, pp. 1728-1731, 2001.
31. B. DeBosch, N. Sambandam, C. Weinheimer, M. Courtois, and A. J. Muslin, "Akt2 regulates cardiac metabolism and cardiomyocyte survival," Journal of Biological Chemistry, vol. 281, no. 43, pp. 32841-32851, 2006.
32. Y. Wang, W. Feng, W. Xue et al., "Inactivation of GSK-3β by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling," Diabetes, vol. 58, no. 6, pp. 1391-1402, 2009.
33. P. Razeghi, M. E. Young, T. C. Cockrill, O. H. Frazier, and H. Taegtmeyer, "Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure," Circulation, vol. 106, no. 4, pp. 407-411, 2002.
34. S. Guo, Q. Yao, Z. Ke, H. Chen, J. Wu, and C. Liu, "Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK," Molecular and Cellular Endocrinology, vol. 412, pp. 85-94, 2015.